Search This Blog

Wednesday, January 31, 2024

Vertex Pharmaceuticals Incorporated: Goldman Sachs raises the target price from USD 442 to USD 559.

 maintains its buy recommendation

https://www.marketscreener.com/quote/stock/VERTEX-PHARMACEUTICALS-IN-11321/

Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)